Semnur Pharmaceuticals, Inc.
OTCPKSMNR utilization maxes out at 100%, lowest availability in 52 weeks at just 21.2% as of May 21—short sellers face severe borrowing constraints.
Snapshot as of 26 Jun 2026
No long-form analysis yet for SMNR. Pulse alerts and the live data picture are available on ORTEX.
Open SMNR on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SMNR — free to start on ORTEX.
Sign up for free →Open SMNR on ORTEX